ELV vs MGNX · P/E 18, rev $199.13B vs rev $39.6M
Elevance Health Inc (ELV) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the ELV and MGNX stock pages for the full models.
Not investment advice.